Journal Article
Safety and pharmacodynamics of intranasal recombinant human interferon alpha-2b as antiviral prophylaxis: A phase I-II clinical trial (OLIVO study)
Francisco Hernández-Bernal; Dania Vázquez-Blomquist; Joel M. Quintana-Guerra; Lídice Josué-Díaz; Klaudia Urrutia-Pérez; Karen Urrutia-Pérez; José L. Rodríguez-Reinoso; Jorge C. Castillo-Miranda; Maritza Pacheco-Rodríguez; Iris Valdés-Prado; Marel Alonso-Valdés; Hugo Nodarse-Cuní; Ana Aguilera-Barreto; Verena L. Muzio-González
Next Research · Vol. 2, Issue 3 · pp. 100583 · 2025